Systemic and local inflammation in peritoneal dialysis: Mechanisms, biomarkers and effects on outcome

Contributions to Nephrology

Volumn 163, Issue , 2009, Pages 132-139

  Cordeiro, Antonio Carlos ^a,b   Carrero, Juan Jesús ^a   Abensur, Hugo ^c   Lindholm, Bengt ^a   Stenvinkel, Peter ^a,d  

^a KAROLINSKA INSTITUTE   (Sweden)

^b INSTITUTO DANTE PAZZANESE DE CARDIOLOGIA   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CYTOKINE;

ARTICLE; BLOOD; CHRONIC DISEASE; HUMAN; INFLAMMATION; KIDNEY DISEASE; METABOLISM; PATHOPHYSIOLOGY; PERITONEAL DIALYSIS; PROTEIN CALORIE MALNUTRITION; TREATMENT OUTCOME;

BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CHRONIC DISEASE; CYTOKINES; HUMANS; INFLAMMATION; KIDNEY DISEASES; PERITONEAL DIALYSIS; PROTEIN-ENERGY MALNUTRITION; TREATMENT OUTCOME;

EID: 67651215897     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000223791     Document Type: Article

References (26)

1. Khawar O, Kalantar-Zadeh K, Lo WK, Johnson D, Mehrotra R: Is the declining use of long-term peritoneal dialysis justifi ed by outcome data? Clin J Am Soc Nephrol 2007;2:1317-1328.
2. McDonald S P, Marshall MR, Johnson DW, Polkinghorne KR: Relationship between dialysis modality and mortality. J Am Soc Nephrol 2009;20:155-163.
3. Pecoits-Filho R, Stenvinkel P, Wang AY, Heimburger O, Lindholm B: Chronic inflammation in peritoneal dialysis: the search for the holy grail? Perit Dial Int 2004;24:327-339.
4. Stenvinkel P, Carrero JJ, Axelsson J, Lindholm B, Heimburger O, Massy Z: Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle? Clin J Am Soc Nephrol 2008;3:505-521.
5. Shlipak MG, Fried LF, Crump C, Bleyer AJ, Manolio TA, Tracy R P, Furberg CD, Psaty BM: Elevations of infl ammatory and procoagulant biomarkers in elderly persons with renal insufficiency. Circulation 2003;107:87-92.
6. Stenvinkel P, Alvestrand A: Infl ammation in end-stage renal disease: Sources, consequences, and therapy. Semin Dial 2002;15:329-337.
7. Liu Y, Berthier-Schaad Y, Plantinga L, Fink NE, Tracy R P, Kao WH, Klag MJ, Smith M W, Coresh J: Functional variants in the lymphotoxin-alpha gene predict cardiovascular disease in dialysis patients. J Am Soc Nephrol 2006;17:3158-3166.
8. Carrero JJ, Axelsson J, Avesani CM, Heimburger O, Lindholm B, Stenvinkel P: Being an infl amed peritoneal dialysis patient: a Dante's journey. Contrib Nephrol. Basel, Karger, 2006, vol 150, pp 144-151.
9. Ayus JC, Mizani MR, Achinger SG, Thadhani R, Go AS, Lee S: Effects of short daily versus conventional hemodialysis on left ventricular hypertrophy and infl ammatory markers: a prospective, controlled study. J Am Soc Nephrol 2005;16:2778-2788.
10. Wang AY, Woo J, Lam CW, Wang M, Sea MM, Lui SF, Li PK, Sanderson J: Is single time point C-reactive protein predictive of outcome in peritoneal dialysis patients? J Am Soc Nephrol 2003; 14:1871-1879.
11. Aroeira LS, Aguilera A, Sanchez-Tomero JA, Bajo MA, del Peso G, Jimenez-Heffernan JA, Selgas R, Lopez-Cabrera M: Epithelial to mesenchymal transition and peritoneal membrane failure in peritoneal dialysis patients: pathologic significance and potential therapeutic interventions. J Am Soc Nephrol 2007;18:2004-2013.
12. Honda K, Hamada C, Nakayama M, Miyazaki M, Sherif AM, Harada T, Hirano H: Impact of uremia, diabetes, and peritoneal dialysis itself on the pathogenesis of peritoneal sclerosis: a quantitative study of peritoneal membrane morphology. Clin J Am Soc Nephrol 2008;3:720-728.
13. Kolesnyk I, Noordzij M, Dekker F W, Boeschoten E W, Krediet RT: A positive effect of ACE inhibitors on peritoneal membrane function in long-term PD patients. Nephrol Dial Transplant 2009; 24:272-277.
14. Szeto CC, Chow KM, Kwan BC, Lai KB, Chung KY, Leung CB, Li PK: The relationship between bone morphogenic protein-7 and peritoneal transport characteristics. Nephrol Dial Transplant 2008;23:2989-2994.
15. ten Dijke P, Goumans MJ, Pardali E: Endoglin in angiogenesis and vascular diseases. Angiogenesis 2008;11:79-89.
16. Wang AY, Wang M, Woo J, Lam C W, Lui SF, Li PK, Sanderson JE: Infl ammation, residual kidney function, and cardiac hypertrophy are interrelated and combine adversely to enhance mortality and cardiovascular death risk of peritoneal dialysis patients. J Am Soc Nephrol 2004;15:2186-2194.
17. Davies SJ, Phillips L, Naish PF, Russell GI: Peritoneal glucose exposure and changes in membrane solute transport with time on peritoneal dialysis. J Am Soc Nephrol 2001;12:1046-1051.
18. Charalambous BM, Stephens RC, Feavers IM, Montgomery HE: Role of bacterial endotoxin in chronic heart failure: the gut of the matter. Shock 2007;28:15-23.
19. Churchill DN, Thorpe KE, Nolph KD, Keshaviah PR, Oreopoulos DG, Page D: Increased peritoneal membrane transport is associated with decreased patient and technique survival for continuous peritoneal dialysis patients. The Canada-USA (CANUSA) Peritoneal Dialysis Study Group. J Am Soc Nephrol 1998;9:1285-1292.
20. Chung SH, Heimburger O, Lindholm B: Poor outcomes for fast transporters on PD: The rise and fall of a clinical concern. Semin Dial 2008;21:7-10.
21. Carrero JJ, Heimburger O, Chan M, Axelsson J, Stenvinkel P, Lindholm B: Protein-energy malnutrition/wasting during peritoneal dialysis; in Khanna R, Krediet RT (eds): Nolph and Gokal's Textbook of Peritoneal Dialysis. New York, Springer Science and Business Media, 2009.
22. Nordfors L, Heimburger O, Lonnqvist F, Lindholm B, Helmrich J, Schalling M, Stenvinkel P: Fat tissue accumulation during peritoneal dialysis is associated with a polymorphism in uncoupling protein 2. Kidney Int 2000;57:1713-1719.
23. Axelsson J, Rashid Qureshi A, Suliman ME, Honda H, Pecoits-Filho R, Heimburger O, Lindholm B, Cederholm T, Stenvinkel P: Truncal fat mass as a contributor to infl ammation in end-stage renal disease. Am J Clin Nutr 2004;80:1222-1229.
24. Carrero JJ, Qureshi AR, Axelsson J, Avesani CM, Suliman ME, Kato S, Barany P, Snaedal-Jonsdottir S, Alvestrand A, Heimburger O, Lindholm B, Stenvinkel P: Comparison of nutritional and infl ammatory markers in dialysis patients with reduced appetite. Am J Clin Nutr 2007;85:695-701.
25. Carrero JJ, Qureshi AR, Axelsson J, Yilmaz MI, Rehnmark S, Witt MR, Barany P, Heimburger O, Suliman ME, Alvestrand A, Lindholm B, Stenvinkel P: Clinical and biochemical implications of low thyroid hormone levels (total and free forms) in euthyroid patients with chronic kidney disease. J Intern Med 2007;262:690-701.
26. Carrero JJ, Qureshi AR, Parini P, Arver S, Lindholm B, Barany P, Heimburger O, Stenvinkel P: Low serum testosterone increases mortality risk among male dialysis patients. J Am Soc Nephrol 2009;20:613-620.